IL17A and COVID-19: Of the analyzed pro-inflammatory cytokines, the concentrations of interleukin (IL)-1β, monocyte chemotactic protein 1 (MCP-1), IL-6, IL-8 and IL-17A were significantly higher in severe COVID-19 patients compared to healthy controls (Figure 2a–e).